Assessment of vitamin B₁₂ tissue stores in elderly proton pump inhibitor users

References

• Abraham, N. S. (2012). Proton pump inhibitors: Potential adverse effects. Current Opinion in Gastroenterology, 28, 615–620. doi:10.1097/MOG.0b013e328358d5b9
   PubMed Web of Science ®Google Scholar
• Achem, S. P., & DeVault, K. R. (2014). Gastroesophageal reflux disease and the elderly. Gastroenterology Clinics of North America, 43, 147–160. doi:10.1016/j.gtc.2013.11.004
   PubMed Web of Science ®Google Scholar
• Baik, H. W., & Russell, R. M. (1999). Vitamin B12 deficiency in the elderly. Annual Review of Nutrition, 19, 357–377. doi:10.1146/annurev.nutr.19.1.357
   PubMed Web of Science ®Google Scholar
• Carmel, R. (1997). Cobalamin, the stomach and aging. American Journal of Clinical Nutrition, 66, 750–759.
   PubMed Web of Science ®Google Scholar
• Corley, D. A., & Kubo, A. (2006). Body mass index and gastroesophageal reflux disease: A systematic review and meta-analysis. American Journal of Gastroenterology, 108, 2619–2628. doi:10.1111/j.1572-0241.2006.00849.x
   Web of Science ®Google Scholar
• Den Elzen, W. P. J., Groeneveld, Y., De Ruijter, W., Souverijin, J. H. M., Le Cessie, S., Assendelft, W. J. J., & Gussekloo, J. (2008). Long-term use of proton pump inhibitors and vitamin B12 status in elderly individuals. Alimentary Pharmacology & Therapeutics, 27, 491–497. doi:10.1111/j.1365-2036.2008.03601.x
   PubMed Web of Science ®Google Scholar
• deWinter, J. C. F. (2013). Using the student’s t-test with extremely small sample sizes. Practical Assessment Research & Evaluation, 18, 1–12.
   Google Scholar
• Dharmarajan, T. S., Kanagala, M. R., Murakonda, P., Lebelt, A. S., & Norkus, E. P. (2008). Do acid-lowering agents affect vitamin B12 status in older adults? Journal of the American Medical Directors Association, 9, 162–167. doi:10.1016/j.jamda.2007.10.004
   PubMed Web of Science ®Google Scholar
• El-Serag, H. (2008). The association between obesity and GERD: A review of the epidemiological evidence. Digestive Diseases and Sciences, 53, 2307–2312. doi:10.1007/s10620-008-0413-9
   PubMed Web of Science ®Google Scholar
• El-Serag, H. B., Graham, D. Y., Satia, J. A., & Rabeneck, L. (2005). Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. The American Journal of Gastroenterology, 100, 1243–1250. doi:10.1111/j.1572-0241.2005.41703.x
   PubMed Web of Science ®Google Scholar
• Grober, U., Kisters, K., & Schmidt, J. (2013). Neuroenhancement with vitamin B12 -underestimated neurological significance. Nutrients, 5, 5031–5045. doi:10.3390/nu5125031
   PubMed Web of Science ®Google Scholar
• Hajar, N., Castell, D. O., Ghomrawi, H., Rackett, R., & Hila, A. (2012). Impedance pH confirms the relationship between GERD and BMI. Digestive Diseases and Sciences, 57, 1875–1879. doi:10.1007/s10620-012-2131-6
   PubMed Web of Science ®Google Scholar
• Harris, J.E., Boushey, C., Bruemmer, B., & Archer, S. L. (2008). Publishing nutrition research: A review of nonparametric methods, part 3. Journal of the American Dietetic Association, 108, 1488–1496. doi:10.1016/j.jada.2008.06.426
   PubMedGoogle Scholar
• Hill, M. H., Flatley, J. E., Barker, M. E., Garner, C. C., Manning, N. J., Olpin, S. E., … Powers, H. J. (2013). A vitamin B-12 supplement of 500 μg/d for eight weeks does not normalize urinary methylmalonic acid or other biomarkers of vitamin B-12 status in elderly people with moderately poor vitamin B-12 status. The Journal of Nutrition, 143, 142–147. doi:10.3945/jn.112.169193
   PubMed Web of Science ®Google Scholar
• Hirschowitz, B. I., Worthington, J., & Mohnen, J. (2008). Vitamin B12 deficiency in hypersecretors during long-term acid suppression with proton pump inhibitors. Alimentary Pharmacology & Therapeutics, 27, 1110–1121. doi:10.1111/j.1365-2036.2008.03658.x
   PubMed Web of Science ®Google Scholar
• Ito, T., & Jensen, R. T. (2010). Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium. Current Gastroenterology Reports, 12, 448–457. doi:10.1007/s11894-010-0141-0
   PubMedGoogle Scholar
• Lam, J. R., Schneider, J. L., Zhao, W., & Corley, D. A. (2013). Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA, 310, 2435–2442. doi:10.1001/jama.2013.280490
   PubMed Web of Science ®Google Scholar
• Lukaszuk, J. M., Prawitz, A. D., Shokrani, M., Umoren, J., & Norman, E. (2013). Methylmalonic acid levels in non-elderly adult chronic PPI users. Journal of Human Nutrition & Food Science, 5, 5031–5045.
   Google Scholar
• Lukaszuk, J. M., Umoren, J., Warner, T. S., Shokrani, M., & Norman, E. (2015). Assessment of urinary methylmalonic acid levels in older adults on proton pump inhibitors. EC Nutrition, 2, 259–266.
   Google Scholar
• Masclee, G. M. C., Sturkenboom, M. C. J. M., & Kuipers, E. J. (2014). A benefit-risk assessment of the use of proton pump inhibitors in the elderly. Drugs & Aging, 31, 263–282. doi:10.1007/s40266-014-0166-4
   PubMed Web of Science ®Google Scholar
• Matchar, D. B., Feussner, J. R., Millington, D. S., Wilkinson, D. S., Watson, D. J., & Gale, D. (1987). Isotope-dilution assay for urinary methylmalonic acid in the diagnosis of vitamin B12 deficiency. A prospective clinical evaluation. Annals of Internal Medicine, 106, 707–710. doi:10.7326/0003-4819-106-5-707
   PubMed Web of Science ®Google Scholar
• Norman, E. J. (2004). Urinary methymalonic acid test may have greater value than the total homocysteine assay for screening elderly individuals for cobalamin deficiency. Clinical Chemistry, 50, 1482–1483. doi:10.1373/clinchem.2004.035790
   PubMed Web of Science ®Google Scholar
• Norman, E., & Morrison, J. (1993). Screening elderly populations for cobalamin (vitamin B12) deficiency using the urinary methylmalonic acid assay by gas chromatography mass spectrometry. The American Journal of Medicine, 94, 589–594. doi:10.1016/0002-9343(93)90209-8
   PubMed Web of Science ®Google Scholar
• Rozgony, N. R., Fang, C., & Kuczmarski, M. F. (2010). Vitamin B12 deficiency is linked with long-term use of proton pump inhibitors in institutionalized older adults: Could a cyanocobalamin nasal spray be beneficial. Journal of Nutrition for the Elderly, 29, 87–99. doi:10.1080/01639360903574734
   PubMedGoogle Scholar
• Russell, R. M. (2001). Factors in aging that effect the bioavailability of nutrients. The Journal of Nutrition, 131, 1359S–1361S.
   PubMed Web of Science ®Google Scholar
• Saltzman, J. R., Kemp, J. A., Golner, B. B., Pedrosa, M. C., Dallal, G. E., & Russell, R. M. (1994). Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein-based vitamin B12 absorption. Journal of the American College of Nutrition, 13, 584–591. doi:10.1080/07315724.1994.10718452
   PubMed Web of Science ®Google Scholar
• United States Census Bureau. (2017). Retrieved September 22, 2017, from https://www.census.gov/quickfacts/fact/table/US/PST045216
   Google Scholar
• Valuck, R. J., & Ruscin, J. M. (2004). A case-control study on adverse effects: H2 blockers or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults. Journal of Clinical Epidemiology, 57, 422–428. doi:10.1016/j.jclinepi.2003.08.015
   PubMed Web of Science ®Google Scholar
• Wolters, M., Strohle, A., & Hahn, A. (2004). Cobalamin: A critical vitamin in the elderly. Preventive Medicine, 39, 1256–1266. doi:10.1016/j.ypmed.2004.04.047
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2017). Overweight and Obesity. Retrieved September 22, 2017, from https://who.int/mediacentre/factsheets/fs311/en
   Google Scholar
• Wu, J. C., Mui, L., Cheung, C. M., Chan, Y., & Jao-Yiu Sung, J. (2007). Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology, 132, 883–889. doi:10.1053/j.gastro.2006.12.032
   PubMed Web of Science ®Google Scholar
• Yang, Y., & Metz, D. C. (2010). Safety of proton pump inhibitor exposure. Gastroenterology, 139, 1115–1127. doi:10.1053/j.gastro.2010.08.023
   PubMed Web of Science ®Google Scholar